Renovorx, Inc. insider trading
Every open-market purchase and sale by Renovorx, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $84,494 10 trades by 3 insiders
3 months later: median +14.8% (+14.9% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Renovorx, Inc.’s insiders pay?
From May 23, 2022 to May 21, 2026, 5 insiders reported 13 open-market purchases and 0 sales not made under a pre-set plan in Renovorx, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Agah Ramtin | Chief Medical Officer | 9 | — | — | 0 | — | January 22, 2026 |
| Bagai Shaun | Chief Executive Officer | 1 | — | — | 0 | — | May 23, 2022 |
| Kocak Ron | VP Controller and PAO | 1 | — | — | 0 | — | April 10, 2025 |
| Marton Laurence | Director | 1 | — | — | 0 | — | April 9, 2025 |
| Voll Mark | Chief Financial Officer | 1 | — | — | 0 | — | May 21, 2026 |